Global Health Limited (BOM:543654)
India · Delayed Price · Currency is INR 1,182.80
-26.40 (-2.18%)
At close: May 29, 2026
Global Health Cash Flow Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Net Income | 5,565 | 4,814 | 4,782 | 3,261 | 1,962 |
Depreciation & Amortization | 2,225 | 1,919 | 1,702 | 1,474 | 1,275 |
Other Amortization | - | 18.35 | 25.02 | 25.04 | 22.57 |
Loss (Gain) From Sale of Assets | -0.79 | -2.19 | -8.2 | 6.77 | -2.94 |
Asset Writedown & Restructuring Costs | - | - | - | - | 17.38 |
Loss (Gain) From Sale of Investments | - | 192.25 | 293.13 | 76.19 | - |
Stock-Based Compensation | 382.98 | - | 1.56 | 7.48 | 91.66 |
Provision & Write-off of Bad Debts | 107.85 | - | - | - | 33.36 |
Other Operating Activities | -283.93 | 292.73 | -215.76 | 566.62 | 381.72 |
Change in Accounts Receivable | -1,303 | -949.07 | -484.06 | -214.56 | -495.64 |
Change in Inventory | -118.42 | -2.91 | -64.79 | -69.83 | -136.29 |
Change in Accounts Payable | 535.68 | 125.88 | 17.69 | 603.62 | 27.78 |
Change in Other Net Operating Assets | 33.32 | -170.95 | 72.05 | 708.96 | -63.52 |
Operating Cash Flow | 7,144 | 6,238 | 6,121 | 6,445 | 3,113 |
Operating Cash Flow Growth | 14.53% | 1.91% | -5.03% | 107.07% | 28.74% |
Capital Expenditures | -8,382 | -5,165 | -2,786 | -2,360 | -2,745 |
Sale of Property, Plant & Equipment | 8.47 | 29.94 | 14.27 | 7.97 | 13.84 |
Sale (Purchase) of Real Estate | -1,404 | - | - | - | - |
Investment in Securities | -1,889 | -1,432 | -2,226 | -1,416 | -1,642 |
Other Investing Activities | 775.64 | -641.96 | 589.2 | 344.54 | 163.83 |
Investing Cash Flow | -10,891 | -7,209 | -4,408 | -3,423 | -4,209 |
Long-Term Debt Issued | 3,687 | 1,492 | 1,363 | 390.75 | 2,351 |
Long-Term Debt Repaid | -251.6 | -1,940 | -5,935 | -796.46 | -367.4 |
Total Debt Repaid | -251.6 | -1,940 | -5,935 | -796.46 | -367.4 |
Net Debt Issued (Repaid) | 3,435 | -448.12 | -4,572 | -405.71 | 1,984 |
Issuance of Common Stock | 0.21 | 0.16 | 0.07 | 4,785 | 379.52 |
Repurchase of Common Stock | -98.24 | - | - | - | - |
Common Dividends Paid | -134.4 | - | - | - | - |
Other Financing Activities | -484.08 | -524.3 | -567.12 | -923.4 | -767.27 |
Financing Cash Flow | 2,719 | -972.26 | -5,139 | 3,456 | 1,596 |
Net Cash Flow | -1,029 | -1,944 | -3,426 | 6,478 | 499.66 |
Free Cash Flow | -1,238 | 1,072 | 3,335 | 4,085 | 367.87 |
Free Cash Flow Growth | - | -67.85% | -18.37% | 1010.54% | -61.69% |
Free Cash Flow Margin | -2.81% | 2.90% | 10.18% | 15.08% | 1.69% |
Free Cash Flow Per Share | -4.60 | 3.99 | 12.42 | 15.74 | 1.46 |
Cash Interest Paid | 724.08 | 536.8 | 567.12 | 888.11 | 761.97 |
Cash Income Tax Paid | 1,194 | 1,642 | 1,775 | 1,061 | 980.19 |
Levered Free Cash Flow | -2,142 | 129.77 | 2,208 | 2,931 | -418.52 |
Unlevered Free Cash Flow | -1,647 | 529.92 | 2,661 | 3,415 | 74.96 |
Change in Working Capital | -852.2 | -997.05 | -459.11 | 1,028 | -667.67 |